X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (231) 231
erythropoietic protoporphyria (118) 118
male (112) 112
index medicus (111) 111
female (99) 99
animals (76) 76
adult (57) 57
anemia (55) 55
dermatology (55) 55
middle aged (52) 52
mice (45) 45
congenital erythropoietic porphyria (40) 40
oncology (40) 40
porphyria (40) 40
aged (39) 39
cancer (35) 35
quality-of-life (33) 33
biochemistry & molecular biology (32) 32
anemia - drug therapy (31) 31
erythropoietin (30) 30
erythropoietin - therapeutic use (29) 29
acute intermittent porphyria (28) 28
care and treatment (28) 28
recombinant-human-erythropoietin (28) 28
hematology (27) 27
photosensitivity (27) 27
anemia - etiology (26) 26
double-blind (26) 26
pharmacology & pharmacy (25) 25
hemoglobin (24) 24
treatment outcome (24) 24
erythropoiesis - drug effects (23) 23
medicine, research & experimental (23) 23
epoetin-alpha (21) 21
erythropoiesis (21) 21
medicine & public health (21) 21
recombinant proteins (21) 21
child (20) 20
darbepoetin alfa (20) 20
neoplasms - complications (20) 20
adolescent (19) 19
beta-carotene (19) 19
disease (19) 19
epoetin alfa (19) 19
analysis (18) 18
cutanea-tarda (18) 18
ferrochelatase (18) 18
liver (18) 18
porphyrins (18) 18
risk factors (18) 18
pediatrics (17) 17
cell biology (16) 16
erythropoietic activity (16) 16
erythropoietic agents (16) 16
heme (16) 16
mutation (16) 16
quality of life (16) 16
anaemia (15) 15
anemia - therapy (15) 15
antineoplastic agents - adverse effects (15) 15
cells (15) 15
chemotherapy (15) 15
erythropoietin - administration & dosage (15) 15
gastroenterology & hepatology (15) 15
health aspects (15) 15
hematinics - therapeutic use (15) 15
porphyria, erythropoietic - diagnosis (15) 15
porphyrias (15) 15
young adult (15) 15
child, preschool (14) 14
erythropoietic proteins (14) 14
erythropoietin - analogs & derivatives (14) 14
porphyrins - metabolism (14) 14
protoporphyria, erythropoietic - drug therapy (14) 14
protoporphyrins - metabolism (14) 14
skin (14) 14
aged, 80 and over (13) 13
anemia - chemically induced (13) 13
diagnosis (13) 13
drug therapy (13) 13
erythrocytes (13) 13
erythropoietic stimulating agents (13) 13
heme - biosynthesis (13) 13
hemoglobins - analysis (13) 13
internal medicine (13) 13
light (13) 13
medicine, general & internal (13) 13
neoplasms - drug therapy (13) 13
photosensitivity disorders - etiology (13) 13
placebo-controlled trial (13) 13
porphyrias - diagnosis (13) 13
protoporphyria, erythropoietic - complications (13) 13
therapy (13) 13
transplantation (13) 13
hemoglobins - metabolism (12) 12
mutations (12) 12
porphyria, erythropoietic - complications (12) 12
porphyria, erythropoietic - therapy (12) 12
porphyrias - therapy (12) 12
rats (12) 12
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (324) 324
German (2) 2
Polish (2) 2
Spanish (2) 2
Czech (1) 1
French (1) 1
Japanese (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Haematology, ISSN 0902-4441, 07/2016, Volume 97, Issue 1, pp. 33 - 38
Journal Article
Annals of Hematology, ISSN 0939-5555, 7/2008, Volume 87, Issue 7, pp. 527 - 536
Journal Article
Nature Medicine, ISSN 1078-8956, 04/2013, Volume 19, Issue 4, pp. 418 - 420
Co-therapy with rifampicin (RIF) and isoniazid (INH) used to treat tuberculosis in humans frequently causes liver injury. Here, using a pregnane X receptor... 
MEDICINE, RESEARCH & EXPERIMENTAL | DRUG-INTERACTIONS | GENOTYPE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ERYTHROPOIETIC-PROTOPORPHYRIA | INJURY | LIVER TOXICITY | MODEL | PREGNANE-X-RECEPTOR | CELL BIOLOGY | DISEASE | GENE-EXPRESSION | DEFINES | Antitubercular Agents - adverse effects | Liver - pathology | Receptors, Steroid - metabolism | Humans | Isoniazid - adverse effects | Male | Alanine Transaminase - blood | Drug Therapy, Combination - adverse effects | Rifampin - adverse effects | Liver - drug effects | Heme - biosynthesis | Isoniazid - therapeutic use | Rifampin - therapeutic use | Rifampin - administration & dosage | Chemical and Drug Induced Liver Injury - pathology | Alkaline Phosphatase - blood | Chemical and Drug Induced Liver Injury - etiology | Antitubercular Agents - therapeutic use | Liver - metabolism | Protoporphyrins - biosynthesis | Heme - analysis | Mice, Transgenic | Receptors, Steroid - drug effects | Protoporphyrins - analysis | Liver - chemistry | Isoniazid - administration & dosage | Animals | Chemical and Drug Induced Liver Injury - metabolism | Receptors, Steroid - physiology | Antitubercular Agents - administration & dosage | Mice | Complications and side effects | Transcription factors | Usage | Liver | Analysis | Antitubercular agents | Research | Injuries | Side effects | Pharmacology | Tuberculosis | Drug therapy | Toxicity
Journal Article
Critical Reviews in Oncogenesis, ISSN 0893-9675, 2013, Volume 18, Issue 5, pp. 471 - 483
Anemia commonly accompanies malignancies in patients and may contribute to morbidity. Correction of the anemia with erythropoietic stimulating agents, while... 
Erythropoietic stimulating agents | Iron | Anemia | Cancer | Neoplasms - complications | Anemia - drug therapy | Animals | Neoplasms - blood | Hematinics - therapeutic use | Iron - therapeutic use | Humans | Hematinics - adverse effects | Hemoglobins - analysis
Journal Article
Journal Article